Skip to main content
logo
Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,910.50
-27.50 (-1.42%)
Oct 24, 2025, 4:59 PM CET

Genmab Revenue

Genmab had revenue of $925.00M USD in the quarter ending June 30, 2025, with 18.74% growth. This brings the company's revenue in the last twelve months to $3.65B, up 32.97% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

Revenue (ttm)
$3.65B
Revenue Growth
+32.97%
P/S Ratio
5.08
Revenue / Employee
$1.36M
Employees
2,682
Market Cap
117.60B DKK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.99B545.24M22.32%
Dec 31, 20232.44B358.99M17.23%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 20201.66B855.79M106.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novo Nordisk311.94B
Coloplast27.87B
H. Lundbeck23.52B
Demant22.59B
GN Store Nord17.33B
Zealand Pharma9.11B
Bavarian Nordic6.46B
Ambu A/S5.96B
Revenue Rankings

Genmab News

More News